The MedSeqâ„¢ Project seeks to explore the impact of incorporating information from a patient's whole genome sequence into the practice of clinical medicine. In the extension phase of MedSeq we are attempting increase our participant diversity by increasing targeted enrollment of African/African American patient participants.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Attitudes and Trust
Timeframe: Change at 6-weeks post-results disclosure relative to baseline, administered approx.12.5 months after baseline
Change in Self Efficacy
Timeframe: Baseline and 6-months post-results disclosure (6 mos. follow-up administered approx. 17 months after baseline)
Change in Preferences for WGS Information
Timeframe: Baseline and 6-weeks post-disclosure (6 wks follow-up administered approx. 12.5 mos. after baseline)
Change in Perceived Health
Timeframe: Baseline, at the disclosure visit (about 1 hour after results disclosure, avg. 11 mos. after baseline) and 6-months post-disclosure (6 mos. follow-up follow-up administered approx. 17 months after baseline)
Change in Shared Decision Making
Timeframe: Baseline and 6-weeks post-disclosure (6 wks follow-up administered approx. 12.5 mos. after baseline)
Change in Intolerance of Uncertainty
Timeframe: Baseline and 6-months post-disclosure (6 mos. follow-up administered approx. 17 mos. after baseline)
Change in General Anxiety and Depression
Timeframe: Baseline, at the disclosure visit (about 1 hour after results disclosure, avg. 11 mos. after baseline), 6-weeks post-disclosure and 6-months post-disclosure (6 wks. follow-up administered approx. 12.5 mos and 6 mos follow-up approx 17 mos. after baseline)
Change in Health Behaviors
Timeframe: 6-weeks post-disclosure and 6-months post-disclosure (6 wks. follow-up administered approx. 12.5 mos. and 6 mos. follow-up approx. 17 mos. after baseline)
Information Sharing
Timeframe: At the disclosure visit (about 1 hour after results disclosure, avg. 11 mos. after baseline) and 6-months post-disclosure (approx. 17 mos. after baseline)
Changes in Genomic Literacy
Timeframe: Assessing Genomic Literacy at baseline and 6-months post-disclosure (approx. 17 mos. after baseline)
Changes in Health Care Utilization
Timeframe: 6 months prior to disclosure and 6-months post-disclosure (approx. 17 mos. after baseline) and 5-years post-disclosure
Change in Perceived Utility
Timeframe: At baseline and 6-months post-disclosure (approx. 17 mos. after baseline)